Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Begemann, Marieke J. H.
Thompson, Ilse A.
Veling, Wim
Gangadin, Shiral S.
Geraets, Chris N. W.
van ‘t Hag, Erna
Müller-Kuperus, Sanne J.
Oomen, Priscilla P.
Voppel, Alban E.
van der Gaag, Mark
Kikkert, Martijn J.
Van Os, Jim
Smit, H. Filip E.
Knegtering, Rikus H.
Wiersma, Sybren
Stouten, Luyken H.
Gijsman, Harm J.
Wunderink, Lex
Staring, Anton B. P.
Veerman, Selene R. T.
Mahabir, Amrita G. S.
Kurkamp, Jörg
Pijnenborg, Gerdina H. M.
Veen, Natalie D.
Marcelis, Machteld
Grootens, Koen P.
Faber, Gunnar
van Beveren, Nico J.
Been, Agaath
van den Brink, Truus
Bak, Maarten
van Amelsvoort, Therese A. M. J.
Ruissen, Andrea
Blanke, Christine
Groen, Karin
de Haan, Lieuwe
and
Sommer, Iris E. C.
2020.
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
Trials,
Vol. 21,
Issue. 1,
Ceraso, Anna
LIN, Jessie Jingxia
Schneider-Thoma, Johannes
Siafis, Spyridon
Tardy, Magdolna
Komossa, Katja
Heres, Stephan
Kissling, Werner
Davis, John M
and
Leucht, Stefan
2020.
Maintenance treatment with antipsychotic drugs for schizophrenia.
Cochrane Database of Systematic Reviews,
Vol. 2020,
Issue. 8,
Tani, Hideaki
Takasu, Shotaro
Uchida, Hiroyuki
Suzuki, Takefumi
Mimura, Masaru
and
Takeuchi, Hiroyoshi
2020.
Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials.
Neuropsychopharmacology,
Vol. 45,
Issue. 5,
p.
887.
Shimomura, Yutaro
Kikuchi, Yuhei
Suzuki, Takefumi
Uchida, Hiroyuki
Mimura, Masaru
and
Takeuchi, Hiroyoshi
2020.
Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms.
Schizophrenia Research,
Vol. 215,
Issue. ,
p.
8.
Quattrone, Diego
Richards, Alex
Reininghaus, Ulrich
Vassos, Evangelos
O'Donovan, Michael
Lewis, Cathryn
and
Di Forti, Marta
2020.
Letter to the editor: Is polygenic risk for Parkinson's disease associated with less risk of first episode psychosis?.
Psychological Medicine,
Vol. 50,
Issue. 1,
p.
173.
Kishi, Taro
Ikuta, Toshikazu
Matsuda, Yuki
Sakuma, Kenji
and
Iwata, Nakao
2020.
Aripiprazole vs. brexpiprazole for acute schizophrenia: a systematic review and network meta-analysis.
Psychopharmacology,
Vol. 237,
Issue. 5,
p.
1459.
Zipursky, Robert B.
Odejayi, Gbolahan
Agid, Ofer
and
Remington, Gary
2020.
You say “schizophrenia” and I say “psychosis”: Just tell me when I can come off this medication.
Schizophrenia Research,
Vol. 225,
Issue. ,
p.
39.
2021.
The Maudsley Prescribing Guidelines in Psychiatry.
p.
1.
Béchard, Laurent
Corbeil, Olivier
Malenfant, Esthel
Lehoux, Catherine
Stip, Emmanuel
Roy, Marc-André
and
Demers, Marie-France
2021.
Une approche de la psychopharmacologie des premiers épisodes psychotiques axée sur le rétablissement.
Santé mentale au Québec,
Vol. 46,
Issue. 2,
p.
113.
Kimura, Hiroshi
Kanahara, Nobuhisa
and
Iyo, Masaomi
2021.
Rationale and neurobiological effects of treatment with antipsychotics in patients with chronic schizophrenia considering dopamine supersensitivity.
Behavioural Brain Research,
Vol. 403,
Issue. ,
p.
113126.
Rosenthal Oren, Rotem
Roe, David
Hasson-Ohayon, Ilanit
Roth, Stephanie
Thomas, Elizabeth C.
and
Zisman-Ilani, Yaara
2021.
Beliefs About the Causes of Psychosis Among Persons With Psychosis and Mental Health Professionals: A Scoping Review.
Psychiatric Services,
Vol. 72,
Issue. 10,
p.
1178.
Tao, Tiffany Junchen
Hui, Christy Lai Ming
Lam, Bertha Sze Ting
Ho, Elise Chun Ning
Hui, Priscilla Wing Man
Suen, Yi Nam
Lin, Jessie Jingxia
Tong, Alan Chun Yat
Lee, Edwin Ho Ming
Chan, Sherry Kit Wa
Chang, Wing Chung
and
Chen, Eric Yu Hai
2021.
Mindfulness meditation for Chinese patients with psychosis: A systematic review and meta-analysis.
Schizophrenia Research,
Vol. 237,
Issue. ,
p.
103.
Takeuchi, Hiroyoshi
Takekita, Yoshiteru
Hori, Hikaru
Oya, Kazuto
Miura, Itaru
Hashimoto, Naoki
and
Yasui‐Furukori, Norio
2021.
Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first‐episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms.
Human Psychopharmacology: Clinical and Experimental,
Vol. 36,
Issue. 6,
Pilon, Dominic
Patel, Charmi
Lafeuille, Marie-Hélène
Zhdanava, Maryia
Lin, Dee
Côté-Sergent, Aurélie
Rossi, Carmine
Lefebvre, Patrick
and
Joshi, Kruti
2021.
Economic burden in Medicaid beneficiaries with recently relapsed schizophrenia or with uncontrolled symptoms of schizophrenia not adherent to antipsychotics.
Journal of Managed Care & Specialty Pharmacy,
Vol. 27,
Issue. 7,
p.
904.
Ostuzzi, Giovanni
Vita, Giovanni
Bertolini, Federico
Tedeschi, Federico
De Luca, Beatrice
Gastaldon, Chiara
Nosé, Michela
Papola, Davide
Purgato, Marianna
Del Giovane, Cinzia
Correll, Christoph U
and
Barbui, Corrado
2022.
Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis.
The Lancet Psychiatry,
Vol. 9,
Issue. 8,
p.
614.
Griffiths, Siân Lowri
Lalousis, Paris Alexandros
Wood, Stephen J.
and
Upthegrove, Rachel
2022.
Heterogeneity in treatment outcomes and incomplete recovery in first episode psychosis: does one size fit all?.
Translational Psychiatry,
Vol. 12,
Issue. 1,
Scott, James G
McKeon, Gemma
Malacova, Eva
Curtis, Jackie
Burgher, Bjorn
Macmillan, Iain
Thompson, Andrew
and
Parker, Stephen D
2022.
Quality prescribing in early psychosis: key pharmacotherapy principles.
Australasian Psychiatry,
Vol. 30,
Issue. 3,
p.
341.
Chesney, Edward
Oliver, Dominic
and
McGuire, Philip
2022.
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis.
Psychopharmacology,
Vol. 239,
Issue. 5,
p.
1179.
Deng, Mengjie
Liu, Zhening
Shen, Yanyu
Cao, Hengyi
Zhang, Manqi
Xi, Chang
Zhang, Wen
Tan, Wenjian
Zhang, Jinqiang
Chen, Eric
Lee, Edwin
and
Pu, Weidan
2022.
Treatment Effect of Long-Term Antipsychotics on Default-Mode Network Dysfunction in Drug-Naïve Patients With First-Episode Schizophrenia: A Longitudinal Study.
Frontiers in Pharmacology,
Vol. 13,
Issue. ,
Stürup, Anne Emilie
Hjorthøj, Carsten
Albert, Nikolai
Dolmer, Signe
Birk, Merete
Ebdrup, Bjørn H.
Eplov, Lene Falgaard
Jensen, Heidi
Vernal, Ditte Lammers
Speyer, Helene
Mors, Ole
and
Nordentoft, Merete
2022.
Tapered discontinuation vs. maintenance therapy of antipsychotic medication in patients with first-episode schizophrenia: Obstacles, findings, and lessons learned in the terminated randomized clinical trial TAILOR.
Frontiers in Psychiatry,
Vol. 13,
Issue. ,